Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance

British Journal of Dermatology

Volumn 167, Issue 2, 2012, Pages 252-261

  Kamiya, K ^a   Aoyama, Y ^a   Shirafuji, Y ^a   Hamada, T ^a   Morizane, S ^a   Fujii, K ^a   Hisata, K ^a   Iwatsuki, K ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 3 ANTIBODY; EDETIC ACID; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ACANTHOLYSIS; ACCURACY; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CALCIUM; DESMOGLEIN 3; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEMPHIGUS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 84864414815     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10929.x     Document Type: Article

References (25)

1. Oktarina DA, van der Wier G, Diercks GF, et al. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol 2011; 165: 552-62.
2. Kitajima Y, Aoyama Y,. A perspective of pemphigus from bedside and laboratory-bench. Clin Rev Allergy Immunol 2007; 33: 57-66.
3. Sato M, Aoyama Y, Kitajima Y,. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 2000; 80: 1583-92.
4. Calkins CC, Setzer SV, Jennings JM, et al. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006; 281: 7623-34.
5. Delva E, Jennings JM, Calkins CC, et al. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem 2008; 283: 18303-13.
6. Dusek RL, Godsel LM, Green KJ,. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007; 45: 7-21.
7. Cailliez F, Lavery R,. Cadherin mechanics and complexation: the importance of calcium binding. Biophys J 2005; 89: 3895-903.
8. Buxton RS, Cowin P, Franke WW, et al. Nomenclature of the desmosomal cadherins. J Cell Biol 1993; 121: 481-3.
9. Nollet F, Kools P, van Roy F,. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000; 299: 551-72.
10. Garrod DR, Merritt AJ, Nie Z,. Desmosomal cadherins. Curr Opin Cell Biol 2002; 14: 537-45.
11. Getsios S, Huen AC, Green KJ,. Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 2004; 5: 271-81.
12. Tsunoda K, Ota T, Aoki M, et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003; 170: 2170-8.
13. Yamamoto Y, Aoyama Y, Shu E, et al. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 2007; 282: 17866-76.
14. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-17.
15. Cheng SW, Kobayashi M, Kinoshita-Kuroda K, et al. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002; 147: 261-5.
16. Kwon EJ, Yamagami J, Nishikawa T, et al. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission. J Eur Acad Dermatol Venereol 2008; 22: 1070-5.
17. Harman KE, Seed PT, Gratian MJ, et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775-80.
18. Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-6.
19. Yamamoto T, Takata-Michigami M, Hisamatsu Y, et al. A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds. J Dermatol Sci 2010; 59: 170-5.
20. Ishii K, Harada R, Matsuo I, et al. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 2005; 124: 939-46.
21. Huen AC, Park JK, Godsel LM, et al. Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002; 159: 1005-17.
22. Kitajima Y, Inoue S, Yaoita H,. Effects of pemphigus antibody on the regeneration of cell-cell contact in keratinocyte cultures grown in low to normal Ca++ concentration. J Invest Dermatol 1987; 89: 167-71.
23. Amagai M, Ishii K, Hashimoto T, et al. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 1995; 105: 243-7.
24. Muller R, Svoboda V, Wenzel E, et al. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Exp Dermatol 2006; 15: 606-14.
25. Muller R, Svoboda V, Wenzel E, et al. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 2008; 17: 35-43.